Non-pharmaceutical treatment combats recurring Clostridium Difficile infections
Transplanting human donor fecal microbiota into the colon of a patient infected with Clostridiodes difficile (C. diff) may be the best treatment for those not helped by C. diff targeted antibiotics, according to an article in the Journal of the American Osteopathic Association.
C. diff is the most common healthcare-acquired infection in the United States. It affects nearly half a million patients each year and becomes a recurring infection for nearly a third of them. If untreated, C. diff can lead to sepsis and death.
“Twenty five years ago C. diff infections were easier to manage and often resolved with discontinuation of the initiating antibiotic,” says Robert Orenstein, DO, an infectious disease specialist at Mayo Clinic and lead author on this article. “However, these infections have become increasingly common and pernicious.”
The standard and FDA-approved treatment for C. diff is a course of oral vancomycin, an antibiotic. However, even the medications used to eliminate C. diff can perpetuate the infection by killing off beneficial microbes. Newer antibiotics that more specifically target C. diff have been developed but they can be prohibitively expensive, according to Dr. Orenstein.
“Think of your gut as a forest and C. diff as a weed,” says Dr. Orenstein. “In a thriving forest, weeds barely get a foothold. But if you burn the forest down, the weeds are going to flourish.”
Unlike antibiotics, which are destructive by definition, fecal transplants or microbial replacement therapies, repopulate the gut with a diverse group of microbes that may block the C. diff‘s spore from germinating and propagating disease via its toxins. Transplants have several delivery methods, including enemas, capsules and direct instillation, to replace the diverse flora that maintain health and improve metabolism.
Currently, there are no FDA-approved fecal transplant products and performing fecal transplants is considered an investigational procedure. Dr. Orenstein notes there are several companies with products in Phase 3 clinical trials that could come to market as early as 2020. For this reason he strongly urges healthcare providers to refer patients with recurrent C. diff for these trials rather than for fecal transplants. In the meantime, the FDA reserves fecal transplants for patients who have experienced a second recurrence (third episode) of C. diff infection.
C. diff is common in healthcare settings and public spaces and rarely causes problems in people with healthy gut microbiota and immune systems, according to researchers. However, people who are already ill and taking antibiotics, chemotherapy, or proton pump inhibitors–which all greatly disrupt the gut ecosystem–are at risk. Elderly patients are especially vulnerable.
Dr. Orenstein expects the new treatment options will improve outcomes but says physicians need to assume greater responsibility for prevention.
“One of the most effective things physicians can do is become more responsible with antibiotic prescriptions,” says Dr. Orenstein. “That means only prescribing when they are clearly indicated, not for colds or viral sinus infections. We also must be especially judicious with elderly patients.”
The Latest on: Fecal transplants
via Google News
The Latest on: Fecal transplants
- Woman Becomes Obese After Fecal Transplant From Overweight Donoron January 15, 2021 at 10:30 am
While they may sound totally disgusting, fecal transplants are emerging as a promising treatment for a variety of gastrointestinal diseases, in particular ...
- Fecal Transplants Safe Long Term for Recurrent C. Diffon January 12, 2021 at 2:21 pm
More evidence has emerged for fecal microbiota transplantation (FMT) as a safe option for treating recurrent Clostridioides difficile infection (CDI), according to a survey-based study. FMT was safe ...
- Poor gut health connected to severe COVID-19, new review showson January 12, 2021 at 3:04 am
In a review published this week in mBio, researchers examined emerging evidence suggesting that poor gut health adversely affects COVID-19 prognosis.
- New Research Shows Poor Gut Health Connected to Severe COVID-19 – Probiotics May Help Patientson January 12, 2021 at 3:03 am
Severe cases of COVID-19 often include GI symptoms Chronic diseases associated with severe COVID-19 are also associated with altered gut microbiota A growing body of evidence suggests poor gut health ...
- Microbiome transplants can reprogram immune system to attack tumorson January 6, 2021 at 12:29 am
For the first time in the world, we have successfully fought cancerous tumors by changing the gut microbiome,’ says oncologist.
- TOP GASTROINTESTINAL DOCTORS BORODY AND HAZAN RELEASE HUMOROUS, EASY TO DIGEST BOOK 'LET'S TALK SH!T'on December 28, 2020 at 2:54 pm
t' addressing disease, digestion and fecal transplants. An estimated 188.9 million adult Americans (74.02% of the population) make New Year's resolutions to better themselves each year ...
- Op-Ed: Why an ethical code is needed for fecal microbiome therapyon December 27, 2020 at 4:00 pm
Direct fecal transplants (or fecal bacteriotherapy), where there is a transfer gut microbiota from healthy donors, have shown great promise in treating a range of diseases. An alternative name for ...
- Fecal Transplants May Help Patients With Crohn’s Disease And Other Intestinal Disorderson December 26, 2020 at 4:00 pm
There are lots of different types of transplants for lots of different medical conditions. One of the newest is called a fecal transplant, where the stool of a healthy individual is transferred to ...
- Doctors explain how patient died from fecal transplanton December 22, 2020 at 4:00 pm
Doctors have released new details about the death of a 73-year-old patient who underwent an experimental fecal transplant last spring and died of a subsequent E. coli infection. The report ...
- Should the FDA regulate fecal transplants as if poop is a drug or a bodily tissue?on December 21, 2020 at 4:00 pm
That’s a question the FDA has to answer in order to regulate fecal microbiota transplants (FMT), a treatment in which feces is transferred from a healthy donor to one suffering from ...
via Bing News